FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q4 2019
Top Holdings116 positions
ALLERGAN PLC | 8M | $1.5B | 10.3% | — | — | 3 qtrssince 2019-Q2 | Increased 77 |
STATE STR SPDR S&P 500 ETF T | 4.4M | $1.4B | 9.5% | — | — | — | Increased — |
WELLCARE HEALTH PLANS INC | 2.4M | $792.5M | 5.3% | — | — | 4 qtrssince 2019-Q1 | Increased 62 |
| 2.1M | $514.8M | 3.5% | — | — | 2 qtrssince 2019-Q3 | Increased 77 | |
FIDELITY NATL INFORMATION SV | 3.5M | $484.8M | 3.3% | $99.04 | +24.01% | 5 qtrssince 2018-Q4 | Increased 65 |
WABTEC | 5.1M | $394.4M | 2.7% | $67.57 | +10.71% | 5 qtrssince 2018-Q4 | Decreased 0 |
ELEVANCE HEALTH INC FORMERLY | 1.3M | $377.5M | 2.5% | $246.79 | +14.06% | 5 qtrssince 2018-Q4 | Increased 62 |
ALPHABET INC | 274,903 | $367.6M | 2.5% | $56.21 | +17.82% | 5 qtrssince 2018-Q4 | Increased 59 |
VANECK ETF TRUST | 2.5M | $354.2M | 2.4% | — | — | — | New — |
MICROSOFT CORP | 2.2M | $344.7M | 2.3% | $116.22 | +28.02% | 5 qtrssince 2018-Q4 | Increased 75 |
CHARTER COMMUNICATIONS INC | 683,093 | $331.4M | 2.2% | $285.92 | +68.96% | 5 qtrssince 2018-Q4 | Decreased 0 |
THE CIGNA GROUP | 1.5M | $306.7M | 2.1% | $175.20 | +5.97% | 5 qtrssince 2018-Q4 | Increased 71 |
IQVIA HLDGS INC | 1.9M | $286.6M | 1.9% | $122.21 | +25.57% | 5 qtrssince 2018-Q4 | Decreased 0 |
VISA INC | 1.5M | $286.1M | 1.9% | $135.72 | +31.91% | 5 qtrssince 2018-Q4 | Increased 57 |
MEDICINES COMPANY | 3.3M | $281.6M | 1.9% | — | — | 1 qtr | New 70 |
SALESFORCE INC | 1.7M | $280.5M | 1.9% | $159.59 | 0.00% | 1 qtr | New 70 |
THERMO FISHER SCIENTIFIC INC | 853,160 | $277.2M | 1.9% | $318.98 | 0.00% | 1 qtr | New 70 |
PLAYA HOTELS & RESORTS NV | 30.6M | $257.1M | 1.7% | — | — | 5 qtrssince 2018-Q4 | Unchanged 0 |
PALO ALTO NETWORKS INC | 1.1M | $256.3M | 1.7% | $36.03 | +6.98% | 2 qtrssince 2019-Q3 | Increased 75 |
EQUINIX INC | 416,323 | $243M | 1.6% | $331.96 | +56.36% | 5 qtrssince 2018-Q4 | Increased 54 |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $14.8B across 116 positions as of Q4 2019. Top holdings: AGN (10.3%), SPY puts (9.5%), WCG (5.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.
Active quarter - 33 new positions, 18 exits, 39 increased. Top move: AGN (INCREASED, conviction 77). Portfolio: $14.8B across 116 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR